$HONA

Jim Cramer Revealed What Went Wrong With Honeywell Aerospace Inc. (NASDAQ:HONA)

Jim Cramer discussed Honeywell Aerospace Inc. (HONA) after its Aug. 6 drop following Q2 results released Aug. 5. He said the company missed due to being overly hopeful about supply chain issues and delayed disclosure. HONA also cut its full-year 2026 organic sales growth forecast to 4% to 5% from 7% to 9%, and CFO noted investments may weigh on near-term performance.

Original reporting
Published Aug 15, 2026, 10:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jim Cramer Revealed What Went Wrong With Honeywell Aerospace Inc. (NASDAQ:HONA) — source image
Decision brief

The 30-second read

$HONABearishMed
01

Why it matters

The key tradable takeaway is the lowered full-year 2026 organic sales growth forecast (4% to 5% from 7% to 9%) alongside admissions that supply-chain ramp did not meet expectations, with near-term investment drag.

02

Market read

Investors may focus on execution credibility and the magnitude of the guidance reset, using the supply-chain ramp admissions as a risk signal.

03

What to watch

The article is commentary from Jim Cramer; it does not add new operational metrics beyond the already-reported guidance cut and general ramp/investment statements.

Relevance 6/10Novelty 5/10Timing: post-Q2 earnings commentary, after Aug 6 stock drop

Background

Honeywell Aerospace is the aerospace spinoff of Honeywell International, and this is the first earnings period since the spinoff.

Company-level read

Ticker impact

$HONABearishMedium confidence
Context

Cramer criticizes Honeywell Aerospace’s Q2 reporting, saying supply-chain issues were not disclosed until results and guidance was cut to 4% to 5%.

Expected impact

Near-term downside bias as investors may reprice delivery reliability and margin risk until ramp progress is proven.

Evidence & confidence

The newest concrete facts are the lowered 2026 organic sales growth forecast and management’s admission that supply chain ramp missed expectations, plus CFO commentary that investments will dampen near-term performance.

Market effects

Reinforces that aerospace spinoffs and suppliers can face ramp and disclosure-timing risk, potentially pressuring investor confidence in similar execution stories.

No clear regional-specific impact described.

No explicit global macro or international regulatory linkage beyond supply-chain execution.

Counterpoint

The supply-chain issues may be transient, and management’s stated integration plan could improve predictability, making the guidance cut a conservative but temporary reset.

Key entities

  • Honeywell Aerospace Inc.

    Aerospace spinoff whose Q2 results included a lowered full-year organic sales growth forecast and supply-chain ramp issues.

  • Jim Cramer

    Provides critique of the company’s disclosure timing and execution, referencing the Q2 earnings and guidance cut.

  • Jim Currier

    CEO quoted as admitting supply chain ramp was unable to meet expectations and describing integration initiatives.

  • Joshua Jepsen

    CFO quoted as saying investments to meet spares capacity will dampen near-term financial performance.

Related articles

$HONAHighAI 8/10

Honeywell Aerospace upgraded to Overweight by Morgan Stanley

Honeywell Aerospace (HONA) shares rose 5.5% after Morgan Stanley upgraded it to Overweight with a $205 price target. The firm cited attractive valuations at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, despite operational challenges and legal investigations. The company reported Q2 sales of $4.52B and an $18.2B backlog but cut full-year guidance due to supply chain issues.

$HONAHigh

Honeywell Aerospace Stock Upgraded to Overweight Following Sell-Off - Honeywell Aerospace (NASDAQ:HONA)

Morgan Stanley upgraded Honeywell Aerospace (HONA) to Overweight with a $205 price target, citing a 25% sell-off post-spin-off and discounted valuation. HONA trades at 16.8x 2028 P/FCF and 11.4x 2028 EV/EBITDA, 35-38% below peers. Q2 sales were $4.52B, up 5% organically, but supply chain issues led to trimmed guidance. CEO Jim Currier acknowledged execution delays but noted localized issues and efforts to dual-source suppliers and expand capacity.

$HONAMed

Honeywell Aerospace is now too cheap to ignore, says Morgan Stanley

Morgan Stanley upgraded Honeywell Aerospace (HONA) to overweight, citing a 28% upside to $205. Despite concerns over growth and margins, the bank sees the stock's valuation as too cheap, trading at a 35% discount to peers. Shares have fallen 24% in a month and 27% since the June spin-off from Honeywell.